Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Psychometric Validation of Two Brief Measures to Assess Palliative Need in Patients Severely Affected by Multiple Sclerosis.
CD21 positive B cell: A novel target for treatment of multiple sclerosis.
Mycobacterium avium subsp. paratuberculosis and multiple sclerosis in Sardinian patients: epidemiology and clinical features.
Subclinical Optic Neuritis in Neuromyelitis Optica.
Activated microglia enhance neurogenesis via trypsinogen secretion.
Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use.
Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies.
Role of Chlamydia in Multiple Sclerosis.
Fatigue is associated with poor sleep in people with multiple sclerosis and cognitive impairment.
Chemokine receptor expression of T cells in the cerebrospinal fluid of relapsing multiple sclerosis.
S1P signaling: new therapies and opportunities.
TREM2 regulates microglial cell activation in response to demyelination in vivo.
"Liberation treatment" for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you free.
Efficacy of lower fingolimod doses in the treatment of MS.
Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability.
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
Identification of a Selective RORγ Ligand That Suppresses T(H)17 Cells and Stimulates T Regulatory Cells.
Multicontrast MR Imaging at 7T in Multiple Sclerosis: Highest Lesion Detection in Cortical Gray Matter with 3D-FLAIR.
CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica.
Oligodendrogenesis from neural stem cells: Perspectives for remyelinating strategies.
Mast cells on the mind: new insights and opportunities.
Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study.
Successful treatment for neuromyelitis optica with systemic lupus erythematosus.
Management of faecal incontinence and constipation in adults with central neurological diseases.
Regulatory T-cell vaccination independent of auto-antigen.
Pages
« first
‹ previous
…
380
381
382
383
384
385
386
387
388
…
next ›
last »